211 related articles for article (PubMed ID: 16942034)
21. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
22. Bifunctional μ/δ opioid peptides: variation of the type and length of the linker connecting the two components.
Ding J; Lemieux C; Chung NN; Schiller PW
Chem Biol Drug Des; 2012 Feb; 79(2):186-93. PubMed ID: 22070627
[TBL] [Abstract][Full Text] [Related]
23. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
24. Assessment of substitution in the second pharmacophore of Dmt-Tic analogues.
Santagada V; Balboni G; Caliendo G; Guerrini R; Salvadori S; Bianchi C; Bryant SD; Lazarus LH
Bioorg Med Chem Lett; 2000 Dec; 10(24):2745-8. PubMed ID: 11133082
[TBL] [Abstract][Full Text] [Related]
25. Crystal structures of dipeptides containing the Dmt-Tic pharmacophore.
Bryant SD; George C; Flippen-Anderson JL; Deschamps JR; Salvadori S; Balboni G; Guerrini R; Lazarus LH
J Med Chem; 2002 Dec; 45(25):5506-13. PubMed ID: 12459018
[TBL] [Abstract][Full Text] [Related]
26. Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligands.
Li T; Shiotani K; Miyazaki A; Tsuda Y; Ambo A; Sasaki Y; Jinsmaa Y; Marczak E; Bryant SD; Lazarus LH; Okada Y
J Med Chem; 2007 Jun; 50(12):2753-66. PubMed ID: 17497839
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging.
Ryu EK; Wu Z; Chen K; Lazarus LH; Marczak ED; Sasaki Y; Ambo A; Salvadori S; Ren C; Zhao H; Balboni G; Chen X
J Med Chem; 2008 Mar; 51(6):1817-23. PubMed ID: 18311909
[TBL] [Abstract][Full Text] [Related]
28. New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores.
Neumeyer JL; Peng X; Knapp BI; Bidlack JM; Lazarus LH; Salvadori S; Trapella C; Balboni G
J Med Chem; 2006 Sep; 49(18):5640-3. PubMed ID: 16942040
[TBL] [Abstract][Full Text] [Related]
29. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
[TBL] [Abstract][Full Text] [Related]
30. A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.
Yamamoto T; Nair P; Vagner J; Largent-Milnes T; Davis P; Ma SW; Navratilova E; Moye S; Tumati S; Lai J; Yamamura HI; Vanderah TW; Porreca F; Hruby VJ
J Med Chem; 2008 Mar; 51(5):1369-76. PubMed ID: 18266313
[TBL] [Abstract][Full Text] [Related]
31. A chimeric opioid peptide with mixed mu agonist/delta antagonist properties.
Weltrowska G; Lemieux C; Chung NN; Schiller PW
J Pept Res; 2004 Feb; 63(2):63-8. PubMed ID: 15009527
[TBL] [Abstract][Full Text] [Related]
32. Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.
Lee YS; Petrov R; Park CK; Ma SW; Davis P; Lai J; Porreca F; Vardanyan R; Hruby VJ
J Med Chem; 2007 Nov; 50(22):5528-32. PubMed ID: 17927164
[TBL] [Abstract][Full Text] [Related]
33. Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogue.
Labarre M; Butterworth J; St-Onge S; Payza K; Schmidhammer H; Salvadori S; Balboni G; Guerrini R; Bryant SD; Lazarus LH
Eur J Pharmacol; 2000 Oct; 406(1):R1-3. PubMed ID: 11011049
[TBL] [Abstract][Full Text] [Related]
34. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.
Elliott J; Traynor JR
Br J Pharmacol; 1995 Mar; 114(5):1064-8. PubMed ID: 7780641
[TBL] [Abstract][Full Text] [Related]
35. Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic.
Balboni G; Salvadori S; Marczak ED; Knapp BI; Bidlack JM; Lazarus LH; Peng X; Si YG; Neumeyer JL
Eur J Med Chem; 2011 Feb; 46(2):799-803. PubMed ID: 21216504
[TBL] [Abstract][Full Text] [Related]
36. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
[TBL] [Abstract][Full Text] [Related]
37. Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502).
Salvadori S; Fiorini S; Trapella C; Porreca F; Davis P; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Balboni G
Bioorg Med Chem; 2008 Mar; 16(6):3032-8. PubMed ID: 18178091
[TBL] [Abstract][Full Text] [Related]
38. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
[TBL] [Abstract][Full Text] [Related]
39. Opioid pseudopeptides containing heteroaromatic or heteroaliphatic nuclei.
Balboni G; Salvadori S; Guerrini R; Bianchi C; Santagada V; Calliendo G; Bryant SD; Lazarus LH
Peptides; 2000 Nov; 21(11):1663-71. PubMed ID: 11090920
[TBL] [Abstract][Full Text] [Related]
40. Novel Dmt-Tic dipeptide analogues as selective delta-opioid receptor antagonists.
Pagé D; McClory A; Mischki T; Schmidt R; Butterworth J; St-Onge S; Labarre M; Payza K; Brown W
Bioorg Med Chem Lett; 2000 Jan; 10(2):167-70. PubMed ID: 10673103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
